Oncology Times - OncTimes Talk

Oncology Times - OncTimes Talk

Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
200 episodios disponibles

Latest episodes of the podcast Oncology Times - OncTimes Talk

Mostrando página 3 de 10

World-Wide Clinical Perspectives from Chinese Society of Clinical Oncology’s Globally Upscale 2024 Annual Meeting 03/10/2024
Breastfeeding is Safe After Treatment for BRCA-Positive Breast Cancer 27/09/2024
Breastfeeding After Hormone Receptor-Positive Breast Cancer: No Detectable Risk for Patients 26/09/2024
Findings at ESMO 2024 Highlighting the Benefit of Neoadjuvant Therapies 26/09/2024
HPV Vaccination Prevents HIV-Related Cancers in Men 10/07/2024
A Multi-Drug Algorithm Used to Accurately Predict Best First-Line Treatments in Patients With Newly Diagnosed Acute Myeloid Leukemia 09/07/2024
Immune-Related Adverse Events Predict Response to Checkpoint Inhibitor Monotherapy in Advanced Head & Neck Cancers 09/07/2024
Proton Pump Inhibitors Bigger Impact on Dasatinib Efficacy in CML Than Previously Thought 09/07/2024
Lymphadenectomy Can Be Safely Omitted for Patients With Advanced Epithelial Ovarian Cancer Lacking Suspicious Lymph Nodes 25/06/2024
MUC-1 Vaccine Delays Breast Cancer Distant Recurrence & Extends Survival 25/06/2024
Neoadjuvant Checkpoint Inhibitor Combination Beats Standard Surgery With Adjuvant Immunotherapy in Macroscopic, Resectable Stage III Melanoma 25/06/2024
Telehealth Triumphs for Palliative Care Delivery in Patients With Lung Cancer 25/06/2024
Asciminib May Be a Safer, More Effective Treatment for Patients With Newly Diagnosed Chronic Myeloid Leukemia 19/06/2024
Chemotherapy Before and After Surgery Improved Outcomes for Patients With Resectable Locally Advanced Esophageal Adenocarcinoma 18/06/2024
Trastuzumab Deruxtecan Delays Progression in HR+, HER2-low, and HER2 Ultralow Breast Cancer After Endocrine Therapy 18/06/2024
German Study Finds New Regimen for Hodgkin Lymphoma More Effective, Less Toxic 11/06/2024
Study Finds Durvalumab Improved Progression-Free and Overall Survival in Limited Stage Small Cell Lung Cancer 11/06/2024
Study Supports Osimertinib as Standard of Care for Patients With Locally Advanced EGFR-Mutated NSCLC 11/06/2024
Earliest Detection of Cancer by Artificial Intelligence Analysis of Circulating Cell-Free DNA Fragmentomes 28/05/2024
Kinase Inhibitor Delivers Synthetic Lethality to Enhance Radiotherapy in Glioblastoma 28/05/2024
« Primera ‹ Anterior 1 2 3 4 5 ... 10 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA